These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 9758358)
21. [Clinical observations on the use of bone marrow transplantation in the treatment of various diseases of the blood system]. EFENDIEV FA; AKHUNDOVA AM; TER-MKRTYCHEVA OKh; RAGIMOV ShR Probl Gematol Pereliv Krovi; 1961 Feb; 6():30-3. PubMed ID: 13725848 [No Abstract] [Full Text] [Related]
22. Rapid autologous marrow recovery and eradication of infectious mononucleosis despite severe immunosuppression following second transplantation for aplastic anemia. Rossbach HC; Hosler KM; Chamizo W; Mueller T; Grana NH; Lacson AG; Barbosa JL Bone Marrow Transplant; 1999 Jan; 23(1):91-3. PubMed ID: 10037057 [TBL] [Abstract][Full Text] [Related]
23. Leukaemic transformation of donor cells in a patient receiving a second allogeneic bone marrow transplant for severe aplastic anaemia. Lawler M; Locasciulli A; Longoni D; Schiro R; McCann SR Bone Marrow Transplant; 2002 Mar; 29(5):453-6. PubMed ID: 11919737 [TBL] [Abstract][Full Text] [Related]
24. [What is the treatment for acute leukemia and aplastic anemia?]. Danielsson K; Gahrton G; Heimdahl A; Liliemark J; Paul C; Ringden O Tandlakartidningen; 1984 Oct; 76(19):1063-70. PubMed ID: 6396896 [No Abstract] [Full Text] [Related]
25. [Bases of bone marrow transplantation: modalities and indications]. García Laraña J Rev Clin Esp; 1999 Apr; 199 Suppl 1():14-21. PubMed ID: 10422446 [No Abstract] [Full Text] [Related]
26. Immunotherapy for severe aplastic anemia following orthotopic liver transplantation in children. Sanchez R; Rosenthal P; Goldsby R Pediatr Blood Cancer; 2007 Jul; 49(1):93-8. PubMed ID: 16395686 [TBL] [Abstract][Full Text] [Related]
27. Analysis of 500 bone marrow transplants from unrelated donors (UR-BMT) facilitated by the Japan Marrow Donor Program: confirmation of UR-BMT as a standard therapy for patients with leukemia and aplastic anemia. Kodera Y; Morishima Y; Kato S; Akiyama Y; Sao H; Matsuyama T; Kawa K; Sakamaki H; Nakagawa S; Hirabayashi N; Dohi H; Okamoto S; Hiraoka A; Gondo H; Tsuchida M; O H; Harada M; Asano S; Juji T; Sasazuki T; Takaku F Bone Marrow Transplant; 1999 Nov; 24(9):995-1003. PubMed ID: 10556959 [TBL] [Abstract][Full Text] [Related]
28. Bone marrow transplantation: a concise overview. Gumbart C J La State Med Soc; 1981 Nov; 133(11):170-3. PubMed ID: 7033419 [No Abstract] [Full Text] [Related]
29. Double bone marrow transplantation for severe aplastic anemia after orthotopic liver transplantation: implications for clinical management and immune tolerance. Stachel D; Schmid I; Lang T; Haas RJ; Otté JB Transpl Int; 2002 Jan; 15(1):39-44. PubMed ID: 11875612 [TBL] [Abstract][Full Text] [Related]
30. [Immunosuppressive-associated encephalopathy in bone marrow transplant recipients]. Ohta K; Yoritaka A; Sakamaki H; Kishida S; No To Shinkei; 2004 May; 56(5):395-401. PubMed ID: 15279197 [TBL] [Abstract][Full Text] [Related]
31. Graft failure and severe autoimmune haemolysis following fludarabine-based reduced-intensity matched unrelated donor bone marrow transplantation for severe aplastic anaemia: salvage by second transplant with conventional dose conditioning. Cutting R; Ezaydi Y; Edbrooke D; El-Ghariani K; Stamps R; Snowden JA Bone Marrow Transplant; 2006 Aug; 38(4):317-8. PubMed ID: 16819439 [No Abstract] [Full Text] [Related]
32. 5-year survival after bone marrow transplantation for aplastic anemia. Pokorski RJ J Insur Med; 1998; 30(4):237-9. PubMed ID: 10537929 [TBL] [Abstract][Full Text] [Related]
33. Consensus Conference on the Treatment of Aplastic Anemia. Kojima S; Nakao S; Tomonaga M; Hows J; Marsh J; Gerard S; Bacigalupo A; Mizoguchi H Int J Hematol; 2000 Jul; 72(1):118-23. PubMed ID: 10979223 [TBL] [Abstract][Full Text] [Related]
34. [Allogenic hematopoietic stem cell transplantation in acquired aplastic anemia: first experience of the National Center for Bone Marrow Grafting]. Abdelkefi A; Ladeb S; Ben Othman T; Torjman L; Jeddi R; Ben Abdeladhim A Tunis Med; 2001 Oct; 79(10):498-502. PubMed ID: 11910688 [TBL] [Abstract][Full Text] [Related]
35. Donor leukocyte infusion for late graft failure in a patient with severe aplastic anemia after allogeneic bone marrow transplantation. Hashino S; Kondo T; Yonezumi M; Chiba K; Tsutsumi Y; Kondo Y; Tanaka J; Imamura M; Asaka M Bone Marrow Transplant; 2004 Jan; 33(1):133-4. PubMed ID: 14578931 [No Abstract] [Full Text] [Related]
36. [Allogenic bone marrow transplant]. León-Rodríguez E Rev Invest Clin; 1993; 45(1):77-84. PubMed ID: 8484070 [No Abstract] [Full Text] [Related]
37. Importance of bone marrow cell dose in bone marrow transplantation. Paulin T Clin Transplant; 1992 Feb; 6(1):48-54. PubMed ID: 10150090 [TBL] [Abstract][Full Text] [Related]
38. Fatal post-transplant lymphoproliferative disorder following allogeneic bone marrow transplantation for aplastic anemia. Rudzki Z; Werda L; Piatkowska-Jakubas B; Mensah P; Zazula M; Białas M; Skotnicki AB; Stachura J Pol J Pathol; 2002; 53(1):35-40. PubMed ID: 12014224 [TBL] [Abstract][Full Text] [Related]
39. Surviving a bone marrow transplant. Health News; 1999 Aug; 5(10):7. PubMed ID: 15352291 [No Abstract] [Full Text] [Related]
40. Immunophenotypic classification of 28 Burkitt cell lines with monoclonal antibodies and reagent selection for bone-marrow purging. Favrot MC; Philip I; Philip T; Cabrillat H; Pinatel C; Doré JF; Lenoir GM IARC Sci Publ; 1985; (60):447-52. PubMed ID: 3905596 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]